Park West Asset Management LLC Eagle Pharmaceuticals, Inc. Transaction History

Park West Asset Management LLC

$1.24 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$36.86 - $44.5 $16.6 Million - $20 Million	-449,479 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$40.32 - $50.97 $13.8 Million - $17.4 Million	-342,121 Reduced 43.22%	449,479 $18.8 Million
Q4 2020 Feb 16, 2021	BUY	$41.72 - $51.34 $6.47 Million - $7.96 Million	155,062 Added 24.36%	791,600 $36.9 Million
Q3 2020 Nov 16, 2020	SELL	$37.02 - $51.28 $17.9 Million - $24.8 Million	-483,697 Reduced 43.18%	636,538 $27 Million
Q2 2020 Aug 14, 2020	SELL	$43.24 - $55.02 $4.96 Million - $6.31 Million	-114,621 Reduced 9.28%	1,120,235 $53.7 Million
Q1 2020 May 15, 2020	BUY	$34.37 - $60.07 $2.16 Million - $3.78 Million	62,976 Added 5.37%	1,234,856 $56.8 Million
Q4 2019 Feb 14, 2020	BUY	$54.32 - $64.31 $4.27 Million - $5.05 Million	78,581 Added 7.19%	1,171,880 $70.4 Million
Q3 2019 Nov 14, 2019	SELL	$53.25 - $59.98 $11 Million - $12.4 Million	-206,701 Reduced 15.9%	1,093,299 $61.8 Million
Q2 2019 Aug 14, 2019	BUY	$46.61 - $58.45 $11.9 Million - $14.9 Million	254,689 Added 24.36%	1,300,000 $72.4 Million
Q1 2019 May 15, 2019	SELL	$38.66 - $51.82 $181,276 - $242,983	-4,689 Reduced 0.45%	1,045,311 $52.8 Million
Q4 2018 Feb 14, 2019	BUY	$36.72 - $67.73 $11.3 Million - $20.9 Million	308,574 Added 41.62%	1,050,000 $42.3 Million
Q3 2018 Nov 14, 2018	SELL	$66.65 - $83.86 $24.1 Million - $30.4 Million	-362,130 Reduced 32.81%	741,426 $51.4 Million
Q2 2018 Aug 14, 2018	BUY	$51.25 - $76.62 $2.68 Million - $4.01 Million	52,282 Added 4.97%	1,103,556 $83.5 Million
Q1 2018 May 15, 2018	BUY	$52.16 - $66.86 $782,400 - $1 Million	15,000 Added 1.45%	1,051,274 $55.4 Million
Q4 2017 Feb 14, 2018	BUY	$49.6 - $60.87 $6.35 Million - $7.79 Million	128,054 Added 14.1%	1,036,274 $55.4 Million
Q3 2017 Nov 14, 2017	BUY	$46.62 - $60.36 $42.3 Million - $54.8 Million	908,220	908,220 $54.2 Million

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Park West Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Park West Asset Management LLC with notifications on news.

Account